99 related articles for article (PubMed ID: 27935579)
1. MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.
Krowiorz K; Ruschmann J; Lai C; Ngom M; Maetzig T; Martins V; Scheffold A; Schneider E; Pochert N; Miller C; Palmqvist L; Staffas A; Mulaw M; Bohl SR; Buske C; Heuser M; Kraus J; O'Neill K; Hansen CL; Petriv OI; Kestler H; Döhner H; Bullinger L; Döhner K; Humphries RK; Rouhi A; Kuchenbauer F
Blood Cancer J; 2016 Dec; 6(12):e508. PubMed ID: 27935579
[No Abstract] [Full Text] [Related]
2. The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA.
Mangiavacchi A; Sorci M; Masciarelli S; Larivera S; Legnini I; Iosue I; Bozzoni I; Fazi F; Fatica A
Oncotarget; 2016 Sep; 7(37):60155-60168. PubMed ID: 27517498
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.
Shaham L; Vendramini E; Ge Y; Goren Y; Birger Y; Tijssen MR; McNulty M; Geron I; Schwartzman O; Goldberg L; Chou ST; Pitman H; Weiss MJ; Michaeli S; Sredni B; Göttgens B; Crispino JD; Taub JW; Izraeli S
Blood; 2015 Feb; 125(8):1292-301. PubMed ID: 25533034
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
5. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.
Gao XN; Lin J; Gao L; Li YH; Wang LL; Yu L
Leuk Res; 2011 Sep; 35(9):1226-32. PubMed ID: 21724256
[TBL] [Abstract][Full Text] [Related]
7. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
Weng H; Lal K; Yang FF; Chen J
Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
Ke S; Li RC; Lu J; Meng FK; Feng YK; Fang MH
Int J Hematol; 2017 Aug; 106(2):258-265. PubMed ID: 28409330
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.
Schneider E; Staffas A; Röhner L; Krowiorz K; Heuser M; Döhner K; Bullinger L; Döhner H; Fogelstrand L; Rouhi A; Kuchenbauer F; Palmqvist L
Exp Hematol; 2016 Dec; 44(12):1166-1171. PubMed ID: 27619068
[TBL] [Abstract][Full Text] [Related]
11. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p.
Fooladinezhad H; Khanahmad H; Ganjalikhani-Hakemi M; Doosti A
Br J Biomed Sci; 2016 Jul; 73(3):129-133. PubMed ID: 27341144
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
[TBL] [Abstract][Full Text] [Related]
14. Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.
Rizzotto L; Lai TH; Bottoni A; Woyach JA; Lapalombella R; Bloomfield CD; Byrd JC; Sampath D
Leuk Lymphoma; 2018 Jun; 59(6):1461-1465. PubMed ID: 28918688
[No Abstract] [Full Text] [Related]
15. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.
Nowek K; Sun SM; Bullinger L; Bindels EM; Exalto C; Dijkstra MK; van Lom K; Döhner H; Erkeland SJ; Löwenberg B; Jongen-Lavrencic M
Leukemia; 2016 Jan; 30(1):229-37. PubMed ID: 26174629
[TBL] [Abstract][Full Text] [Related]
16. miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia.
Favreau AJ; Cross EL; Sathyanarayana P
Am J Hematol; 2012 Apr; 87(4):442-6. PubMed ID: 22374871
[TBL] [Abstract][Full Text] [Related]
17. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).
Yin JY; Tang Q; Qian W; Qian J; Lin J; Wen XM; Zhou JD; Zhang YY; Zhu XW; Deng ZQ
Int J Clin Exp Pathol; 2014; 7(11):8032-8. PubMed ID: 25550847
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs: new players in AML pathogenesis.
Nicoloso MS; Jasra B; Calin GA
Cancer Treat Res; 2010; 145():169-81. PubMed ID: 20306251
[No Abstract] [Full Text] [Related]
20. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
